AGNP (AANP) HTN Review Questions and Answers Graded A+ 2024
AGNP (AANP) HTN Review Questions and Answers Graded A+ 2024 Goals of Antihypertensive Therapy - ANS ️️ To reduce cardiovascular morbidity and mortality Ultimate goal: Maximally reduce CV risk without decreasing the enjoyment of life Risk Factors for HTN - ANS ️️ Smoking Dyslipidemia Physical inactivity BMI over or equal to 30 Diabetes mellitus: >55 for men and >65 for women(>60) Male gender or postmenopausal female Family history of CV disease: women <65, men<55 Microalbuminuria or est GFR <60ml /min. Doubles the risk of CV diseases, such as: - ANS ️️ CHD, CHF, ischemic and hemorrhagic stroke, renal failure, and peripheral artery disease In African Americans - ANS ️️ HTN appears earlier, is generally more severe, and results in higher rates of morbidity and mortality Persons who are normotensive at 55, have a ___% lifetime risk of developing HTN - ANS ️️ 90%
Geschreven voor
- Instelling
- AGNP AANP
- Vak
- AGNP AANP
Documentinformatie
- Geüpload op
- 18 december 2023
- Aantal pagina's
- 37
- Geschreven in
- 2023/2024
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
agnp aanp htn review questions and answers
Ook beschikbaar in voordeelbundel